Vaccine efficacy of aMycobacterium tuberculosisBeijing‐specific proline‐glutamic acid (PE) antigen against highly virulent outbreak isolates-Reference-Cited by-同舟云学术

Vaccine efficacy of aMycobacterium tuberculosisBeijing‐specific proline‐glutamic acid (PE) antigen against highly virulent outbreak isolates

Published:2019-02-12 Issue:5 Volume:33 Page:6483-6496
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Kwon Kee Woong¹,Choi Hong‐Hee¹,Han Seung Jung¹,Kim Jong‐Seok¹²,Kim Woo Sik¹³,Kim Hongmin¹,Kim Lee‐Han¹,Kang Soon Myung¹,Park Jaehun¹,Shin Sung Jae¹

Affiliation:

1. Department of MicrobiologyInstitute for Immunology and Immunological DiseaseBrain Korea 21 Program for Leading Universities and Students (PLUS) Project for Medical ScienceYonsei University College of Medicine Seoul South Korea

2. Myunggok Medical Research InstituteCollege of MedicineKonyang University Daejeon South Korea

3. Advanced Radiation Technology InstituteKorea Atomic Energy Research Institute Jeongeup South Korea

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Ministry of Health and Welfare

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802604R

Reference55 articles.

1. Rational design of vaccines against tuberculosis directed by basic immunology

2. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

3. Tuberculosis vaccines: Time for a global strategy

4. Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells

5. Mycobacterium bovis BCG Immunization Induces Protective Immunity against Nine Different Mycobacterium tuberculosis Strains in Mice

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice;npj Vaccines;2024-03-08

2. Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains;Vaccine;2024-03

3. Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection;Antimicrobial Agents and Chemotherapy;2022-09-20

4. Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion;Frontiers in Cellular and Infection Microbiology;2022-07-28

5. Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx;Nature Communications;2022-06-07